1. Home
  2. MIST vs DIT Comparison

MIST vs DIT Comparison

Compare MIST & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • DIT
  • Stock Information
  • Founded
  • MIST 2003
  • DIT 1981
  • Country
  • MIST Canada
  • DIT United States
  • Employees
  • MIST N/A
  • DIT N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • DIT Food Distributors
  • Sector
  • MIST Health Care
  • DIT Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • DIT Nasdaq
  • Market Cap
  • MIST 98.1M
  • DIT 78.7M
  • IPO Year
  • MIST N/A
  • DIT 1995
  • Fundamental
  • Price
  • MIST $0.88
  • DIT $119.00
  • Analyst Decision
  • MIST Strong Buy
  • DIT
  • Analyst Count
  • MIST 2
  • DIT 0
  • Target Price
  • MIST $17.00
  • DIT N/A
  • AVG Volume (30 Days)
  • MIST 4.5M
  • DIT 222.0
  • Earning Date
  • MIST 03-13-2025
  • DIT 04-17-2025
  • Dividend Yield
  • MIST N/A
  • DIT 0.84%
  • EPS Growth
  • MIST N/A
  • DIT N/A
  • EPS
  • MIST N/A
  • DIT 5.93
  • Revenue
  • MIST N/A
  • DIT $2,202,495,291.00
  • Revenue This Year
  • MIST N/A
  • DIT N/A
  • Revenue Next Year
  • MIST $1,105.43
  • DIT N/A
  • P/E Ratio
  • MIST N/A
  • DIT $20.05
  • Revenue Growth
  • MIST N/A
  • DIT 7.62
  • 52 Week Low
  • MIST $0.75
  • DIT $115.37
  • 52 Week High
  • MIST $2.75
  • DIT $187.00
  • Technical
  • Relative Strength Index (RSI)
  • MIST 30.59
  • DIT 41.56
  • Support Level
  • MIST $1.86
  • DIT $115.37
  • Resistance Level
  • MIST $2.36
  • DIT $125.48
  • Average True Range (ATR)
  • MIST 0.23
  • DIT 2.75
  • MACD
  • MIST -0.06
  • DIT -0.88
  • Stochastic Oscillator
  • MIST 7.43
  • DIT 24.80

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: